Vascular Health and Risk Management
Volume 12, 2016 - Issue
Open access
213
Views
10
CrossRef citations to date
0
Altmetric
Review
SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives
Holly E GurgleDepartment of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USACorrespondence[email protected]
, Karen WhiteDepartment of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA
& Carrie McAdam-MarxDepartment of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA
Pages 239-249
|
Published online: 04 Jun 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.